ONCO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Mai 2024 @ 22:00):

Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide...

Stats
Tagesvolumen	3.76M
Durchschnittsvolumen	3.80M
Marktkapitalisierung	4.61M
EPS	$0 ( 2024-05-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-16	Singh Ajit	Buy	3 125	Common Stock
2024-02-08	Singh Ajit	Buy	0
2024-02-06	Meier Thomas	Buy	0
2003-12-05	Liberty Media Corp /de/	Sell	22 897 677	Common Stock

INSIDER POWER
100.00
Last 2 transactions
Buy: 3 125 \| Sell: 22 897 677

Volumen Korrelation

Lang: 0.30 (neutral)

Kurz: 0.40 (neutral)

Signal:(51.267) Neutral

Onconetix, Inc. Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Onconetix, Inc. Korrelation - Währung/Rohstoff

0.00
( neutral )

-0.06
( neutral )

-0.21
( neutral )

Onconetix, Inc. Finanzdaten

Annual	2023
Umsatz:	$58 465.00
Bruttogewinn:	$-1.14M (-1 950.17 %)
EPS:	$-2.19

FY	2023
Umsatz:	$58 465.00
Bruttogewinn:	$-1.14M (-1 950.17 %)
EPS:	$-2.19

Financial Reports:

No articles found.

Onconetix, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Onconetix, Inc.

Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children\'s to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.